San Francisco, August 14, 2025 – Arintra, a Texas-based GenAI-native autonomous medical coding platform, has secured $21 million in a Series A funding round led by Peak XV Partners, announced on August 12, 2025. The round, which also saw participation from Endeavor Health Ventures, Y Combinator, Counterpart Ventures, Spider Capital, and Ten13, values the company at an estimated $100 million. The funds will fuel Arintra’s mission to revolutionize healthcare revenue assurance by accelerating product development, scaling its team, and establishing a new Bay Area headquarters to meet growing demand from U.S. health systems and physician groups.
Funding Details: A Strategic Capital Infusion
Founded in 2020 by computer science PhDs Nitesh Shroff (CEO) and Preeti Bhargava (CTO), Arintra leverages generative AI to autonomously code patient charts within electronic health record (EHR) systems like Epic and Athena, reducing coding errors, missed charges, and payment delays. The $21 million raise, following a seed round backed by Peak XV’s Surge program, will enhance Arintra’s platform, which combines large language models with clinical knowledge graphs to deliver precise, auditable coding. The company aims to expand its reach across the $150 billion U.S. healthcare reimbursement market, addressing challenges like coder shortages and complex payer requirements.
Funding Round | Amount Raised | Valuation | Lead Investor | Key Participants |
|---|---|---|---|---|
Series A (Aug 2025) | $21M | ~$100M | Peak XV Partners | Endeavor Health Ventures, Y Combinator, Counterpart Ventures, Spider Capital, Ten13 |
Seed (2022) | Undisclosed | N/A | Peak XV Surge | Y Combinator |
Arintra’s Impact: Transforming Revenue Assurance
Arintra’s platform integrates autonomous medical coding, clinical documentation improvement (CDI), and denial prevention, enabling health systems to secure compliant reimbursements with minimal manual effort. The company has processed over $1 billion in healthcare charges, recovering millions in lost revenue for clients. At Mercyhealth, Arintra achieved a 5.1% revenue increase, a 43% reduction in claim denials, a 50% cut in work queue aging, and a 32% drop in coding costs. Reid Health reported faster accounts receivable and improved coding accuracy across specialties, with CIO Muhammad Siddiqui praising its seamless Epic integration and “hard ROI.”
Bhargava, inspired by a personal experience with a $19,000 hospital bill due to a coding error, emphasized the platform’s holistic approach: “By documenting what was done, coding what was documented, and supporting what was charged, we ensure full, compliant reimbursement at lower costs.” Shroff added, “Reimbursement in healthcare is fundamentally broken. We built Arintra to help providers secure revenue at scale while easing frontline burdens.”
Client | Revenue Increase | Denial Reduction | Work Queue Aging | Coding Cost Reduction |
|---|---|---|---|---|
Mercyhealth | 5.1% | 43% | 50% | 32% |
Reid Health | Improved A/R speed | Reduced denials | N/A | Enhanced accuracy |
Industry Context: A Booming AI-Healthcare Intersection
Arintra’s funding aligns with a surge in AI-driven healthcare investments, exemplified by Cohere’s $500 million raise at a $6.8 billion valuation and Darwinbox’s $40 million from OTPP. The U.S. healthcare sector, grappling with tight margins and rising payer complexity, increasingly relies on AI to streamline operations. Arintra’s focus on revenue cycle management (RCM) taps into a critical pain point, as providers lose billions annually to coding gaps and denials. Mohit Bhatnagar, MD at Peak XV, noted, “Arintra’s autonomous system tackles one of the hardest challenges for providers: translating clinical documentation into accurate insurance codes so they get paid fairly and fast.”
India’s growing influence in global tech, as seen in its overtaking China as the top U.S. smartphone supplier and Darwinbox’s rise in HR tech, provides a broader context for Arintra’s success. While U.S. tariffs, including a 25% duty on Indian imports, pose risks, India’s role as a key Indo-Pacific security partner and space collaborator (e.g., NISAR launch) bolsters cross-border investment confidence.
Challenges and Future Outlook
Arintra faces challenges in scaling its platform amid competitive pressures from RCM players like Waystar and R1 RCM, and navigating U.S. healthcare’s regulatory complexity. Geopolitical risks, such as Trump’s tariff policies and calls to curb Indian tech hiring, could impact its Bay Area expansion. However, its enterprise SaaS model, native EHR integration, and proven ROI position it strongly.
The company plans to double its 50-person team by 2026 and expand its capabilities in denial prevention and CDI. With adoption growing among health systems, Arintra aims to process $5 billion in charges by 2027, cementing its role as a leader in healthcare revenue assurance.
Conclusion: A New Era for Healthcare AI
Arintra’s $21 million Series A, led by Peak XV Partners, marks a pivotal step in transforming healthcare reimbursement through AI. By addressing coding inefficiencies and delivering measurable outcomes, Arintra is poised to redefine how providers navigate the $150 billion RCM market. As India’s tech ecosystem thrives globally—from smartphones to space—Arintra’s rise underscores the power of AI to solve real-world challenges, positioning it as a trailblazer in the healthcare-tech frontier.
